Modafinil: A Review of Neurochemical Actions and Effects on Cognition
The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide, Provigil) is an FDA-approved medication with wake-promoting properties. Pre-clinical studies of modafinil suggest a complex profile of neurochemical and behavioral effects, distinct from those of amphetamine. In addition, modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention-deficit/hyperactivity disorder, and schizophrenia. Cognitive dysfunction may be a particularly important emerging treatment target for modafinil, across these and other neuropsychiatric disorders. We aimed to comprehensively review the empirical literature on neurochemical actions of modafinil, and effects on cognition in animal models, healthy adult humans, and clinical populations. We searched PubMed with the search term 'modafinil' and reviewed all English-language articles for neurochemical, neurophysiological, cognitive, or information-processing experimental measures. We additionally summarized the pharmacokinetic profile of modafinil and clinical efficacy in psychiatric patients. Modafinil exhibits robust effects on catecholamines, serotonin, glutamate, gamma amino-butyric acid, orexin, and histamine systems in the brain. Many of these effects may be secondary to catecholamine effects, with some selectivity for cortical over subcortical sites of action. In addition, modafinil (at well-tolerated doses) improves function in several cognitive domains, including workin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, side effects of alpha agonists like guanfacine and clonidine include high prevalence of somnolence or sedating effects,168,169”
From Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome (2023) · cites this paper as [168]
In the citing paper
“Modafinil, which is approved by the US Food and Drug Administration for the treatment of narcolepsy and its associated daytime sleepiness [59], is a logical candidate to address the hypoactive/sleepy aspects of CDS.”
Citations
Cites
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472 · cited 7×
“Importantly, modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described in the Aston…”
BackgroundMethodResultInfluentialNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 3×
“m Fos in orexin neurons in perfornical area 150 mg/kg i.p. Immunohisto-chemistry Mice Chemelli et al, 1999 75 mg/kg i.p. Immunohisto-chemistry Rat Scammell et al, 2000 No binding to orexin-1 receptor IC50 410mM 125I-human-orexin B displacement Transfected Chinese Hamster Ovary cells Wieland et al,…”
BackgroundAston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 1×
“It appears also that when levels of tonic LC activity are minimal, such as during sleep, grooming, and eating, that phasic responses are also less robust (Aston-Jones and Bloom, 1981).”
BackgroundTask-evoked pupillary responses, processing load, and the structure of processing resources.
Beatty, J. (1982) · Psychological Bulletin · doi:10.1037/0033-2909.91.2.276 · Cited by 1,959 · cited 1×
“…modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described…”
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592 · cited 15×
“Inhibition of DA cell firing in VTA/SN; blocked by Sulpiride 10mM but not by Prazosin 20 mM Extracellular recording Rat brain slice Korotkova et al, 2006 Hyperpolarization of VTA neurons, blocked by Sulpiride 10mM 20–50mM Whole-cell patch clamp Isolated VTA neurons No effect on mesencephalic DA neuron activity 128 mg/…”
BackgroundInfluentialDissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
The role of histamine and the tuberomamillary nucleus in the nervous system
Haas, H., & Panula, P. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1034 · Cited by 929 · cited 5×
“Thalamic NET occupancy: 16, 44% 5, 8 mg/kg i.v. PET with [11C]MeNER Rhesus monkey Madras et al, 2006 NET binding IC50¼ 35.6mM [3H] NE Human Embryo Kidney No effect on pontine NE neuron activity 128 mg/kg i.p. Single-unit recording Rat (anesthetized) Akaoka et al, 1991 Extracellular NE: m in PFC, medial hypothalamus 12…”
BackgroundInfluentialDopaminergic Role in Stimulant-Induced Wakefulness
Wisor, J. P., Nishino, S., Sora, I., Uhl, G. H., Mignot, E., & Edgar, D. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01787.2001 · Cited by 769 · cited 7×
“…extracellular DA levels (measured by microdialysis) that are increased significantly in the rat prefrontal cortex (PFC) (de Saint Hilaire et al, 2001), and in the caudate nucleus of narcoleptic dogs (Wisor et al, 2001), although only minimally in the rat hypothalamus (de Saint Hilaire et al, 2001).”
BackgroundInfluentialThe role of locus coeruleus in the regulation of cognitive performance
Usher, M., Cohen, J. D., Servan-Schreiber, D., Rajkowski, J., & Aston-Jones, G. (1999) · Science · doi:10.1126/science.283.5401.549 · Cited by 715
Research works printed but not linked: 1
- Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC et al (1999b). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30–40. · DOI · Paper page
Cited by
Items 701–735 of 735
Solriamfetol enhances alertness and cognitive performance in micePreprint
Haddar, M., Tzanoulinou, S., Chen, L., Tafti, M., & Vassalli, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.02.631072
An Overview of New Therapies and Brain Imaging Techniques for Treating Disorders of Consciousness
Bhavaraju, K. P., Chaudhari, D. M., Renjen, P. N., Goswami, A., & Ahmad, K. (2025) · Apollo Medicine · doi:10.1177/09760016251334216
“[12] Overall, while the evidence supports modafinil’s role in fostering cognitive improvement in DoC patients, further comprehensive studies are essential to solidify its effectiveness and identify optimal treatment protocols.”
López‐Amador, N. (2025) · Qeios · doi:10.32388/zozbh7.3
Harbi, E., Altundağ, A., & Yarar, E. (2025) · Research Square · doi:10.21203/rs.3.rs-7135896/v1
(2025) · Wiley eBooks · doi:10.1002/9781118941430.refs
Prefrontal cortex mechanisms of the novel cognitive enhancer d-govadine
Nesbit, M. O. (2023) · cIRcle (University of British Columbia) · doi:10.14288/1.0436918 · Cited by 2
Haidinger, E. (2018) · University Library Linz repository (Johannes Kepler Universitat Linz)
Idiopathic Hypersomnia: Clinical Insights and Advances in Diagnosis and Management
Luo, J.-J. (2025) · Journal of Neurology and Experimental Neuroscience · doi:10.17756/jnen.2025-122
“Modafinil and armodafinil, non-amphetamine wake-promoting agents that inhibit dopamine reuptake and may enhance histaminergic and orexinergic signaling, are commonly used first-line [58].”
Mendoza, M., Mateos, D. M., Castro, J. P., Bisagno, V., Urbano, F. J., Torterolo, P., & Costa, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.14.699514
EVALUATION OF COMPARATIVE BIOAVAILABILITY AND BIOEQUIVALENCE ANALYSIS OF TERAZOSIN HYDROCHLORIDE
R, P., SD, R., Gopalan, S., G, D. D., & Chandrasekhar, V. (2026) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2026v19i1.57317
Choi, S., Ji-Aee, K., Kwan-Change, K., & Suk-Hyo, S. (2026) · Fibrosis · doi:10.70322/fibrosis.2026.10003
de Almeida, M. M. S. M. C. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Efficacy and safety of modafinil in post-stroke fatigue: a systematic review and meta-analysis
Petry, I. N. S., Tudella, G. C. N., Maximiano, M. L. D. B., Silva, Y. P., Gonzalez, J. V. P., da Silva, L. R. L., da Silva, J. A. R. L., Camacho, G. C. G., Machado, M. D. O., Soares, L. G. B., et al. (2026) · Neurological Research · doi:10.1080/01616412.2026.2631155
Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review
Gillet, A., Geron, C., Vitello, M. M., & Lejeune, N. (2026) · CNS Drugs · doi:10.1007/s40263-026-01274-z
Riedel, M. (2016) · theses.fr (ABES) · doi:10.70675/1ed2f6bbzd4a3z447bza051zbe3da3783596 · Cited by 4
Arnal, P. J. (2015) · theses.fr (ABES) · doi:10.70675/960d1bc7zacc6z4d84za729zc8d8fbc3df5e · Cited by 1
Wakefulness and its multiple behavioral contexts, role of histamine and orexins
Zhao, Y. (2017) · theses.fr (ABES) · doi:10.70675/51556ff8z2be2z44bdz8247z40bbd14151ec
Salomone, M. (2021) · theses.fr (ABES) · doi:10.70675/774f06d3z0a80z4d86zb041z7fd7802f1965 · Cited by 1
Sarcoidosis and Obstructive Sleep Apnoea: An Intriguing Relationship
Ciccarelli, U., Ghelardini, P., Pisciella, M. C., Zezza, G., Nervoso, A., Giordani, F., Mari, P., Martone, F. M., & Siciliano, M. (2026) · The Open Respiratory Medicine Journal · doi:10.2174/0118743064450100260420103730
Sato, Y., Sakuma, A., & Tomita, H. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261446554
“35 It blocks dopamine transporters and increases dopamine levels in the human brain.”
Aging affects glutamate-enriched functional networks in resting and movie-watching states
Zheng, Z., He, Y., Zhou, Y., Yuan, X., Sun, H., Wang, Z., Li, J., Luo, C., Dong, L., & Yao, D. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122019
Shao, Y., Xu, L., An, X., Zhang, J., Xie, H., Gong, J., Haishui, D., & Huang, Y. (2026) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2026.1832731
“This sustained effect likely reflects modafinil’s continuous promotion of prefrontal executive control (Minzenberg and Carter, 2008; Volkow et al., 2009).”
Dilweg, M. A., Jespers, W., Kasture, A. S., Liu, R., Mocking, T. A. M., Ploeg, J. G. V. D., Baselier, M. M., van Westen, G. J. P., Hummel, T., Sučić, S., et al. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00112b
“7,11 12 – 16 Most DRIs investigated so far have been based on a few key chemical scaffolds.”
de Lima, M. S., Coelho, F. M. S., de Lima, H. A., de Souza, D., Fernandes, M. S., Lourenço, J. D., & do Prado-Lima, P. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.109116
Molina-Romero, O. I., Villegas-Gomez, G. A., Ramírez-Romero, A., Sandoval-Rojas, J. D., Melo, N., Villegas, A., Sierra, L. F., Cifuentes, M. F., Jiménez-Hakim, E., Quintero-Rueda, D., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10489832/v1
Clinical presentation of modafinil associated psychosis and review of reported cases
Alkhatib, S., Akbani, I., Musmar, H., Maris, C., Chahal, J., Chughtai, N., Reese, M. S., & Nichols, J. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00325-x
“Unlike classical stimulants, which primarily exert their effects through direct dopaminergic release, modafinil acts through multiple neurotransmitter systems involved in wakefulness and cognitive arousal [3, 4].”
Alam, N., & Abbasi, S. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00316
Manea, M. M., Crintea, A., Singalievici, P.-A., Codrea, M. I. M., & Coman, H. G. (2026) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2975
“While these effects support wakefulness and cognitive endurance, they also implicate circuits critical for affective regulation, impulse control, and behavioral inhibition [4,5,6].”
Lewkowicz, R., Przewodzka, A., & Łaszczyńska, J. (2026) · The Polish Journal of Aviation Medicine Bioengineering and Psychology · doi:10.13174/pjambp.25.08.2026.01
BindingDB Entry 50040332: Histamine H3 receptor as a drug discovery target.
BindingDB (2013) · UC San Diego · doi:10.7270/q2vq33rv
Cognitive impairment: quantification and possibilities for pharmacological treatment
Housden, C. R. (2013) · Apollo (University of Cambridge) · doi:10.17863/cam.16550
“Following loss of a night’s sleep, modafinil has been shown to improve performance on attention and memory tests, such as choice reaction time, paired-associates memory, and n-back memory tasks (Bonnet, Balkin et al. 2005; Wesensten 2006; Minzenberg and Carter 2008).”
Method
Metadata
- Authors
- Minzenberg, M. J., & Carter, C. S.
- Affiliations
- University of California Davis Medical Center (US)
- Corresponding author
- Minzenberg, Michael J
- Venue
- Neuropsychopharmacology
- Published
- 2007-08-22
- Volume
- 33
- Issue
- 7
- Pages
- 1477-1502
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2122011624
- Semantic Scholar
- cf5b2a15296e7832bcfdd965f28583772ef2999c
- Cited by
- 713
- References
- 215
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 25 · 2023: 33 · 2022: 33 · 2021: 46 · 2020: 26 · 2019: 19 · 2018: 33 · 2017: 42 · 2016: 22 · 2015: 49 · 2014: 48 · 2013: 62 · 2012: 59
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 59883, MH066629, R01MH059883, R01MH066629)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- modafinil, wakefulness-promoting agents, neurochemical mechanisms, cognition, catecholamines, serotonin, glutamate, GABA, orexin, histamine, working memory, episodic memory, prefrontal cortex, cognitive control, treatment-resistant depression, attention deficit hyperactivity disorder, schizophrenia, cognitive impairment, pharmacokinetics, abuse liability
- MeSH terms
- Modafinil, Animals, Mental Disorders, Benzhydryl Compounds, Brain Chemistry, Cognition, Humans, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.